Caraco Pharmaceutical Labortories Ltd  (CPD) Trade Now »     Rate CPD  -  Discuss CPD  -  Add to Watch List        

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

CPD: Bull or Bear?

From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Analysis of Generic Drug Companies from India CPD

76%

+20.82% in 7 days Analysis of Generic Drug Companies from India The accompanying table includes the Top 25 rated companies with market caps over $50M U.S. Dollar which are included in the ETF Innovators [ETFI] Indian Generic Drug Index as a major component in the Global Generic Drug Index. The index also includes three companies based outside of India – Akorn (AKRX), Caraco Pharma (CPD), and Taro Pharma (TAROF). Akorn has a joint venture with Strides Arcolab (Akorn-Strides, LLC) which is focused on the hospital market for generic injectables, dominated by Hospira (HSP) and A ... Continue reading »

10 Under the Radar Small & Micro-Cap Value Stocks CPD

76%

-42.40% in 9 days (closed on 11/24/08) 10 Under the Radar Small & Micro-Cap Value Stocks (Healthcare) The accompanying table presents 10 small and micro-cap companies from a variety of industries which are trading at value parameters, with average valuations for the group of 0.54X trailing 12-month sales, 0.44X enterprise value to sales, 0.88X book value, and 8.7X trailing 12-month earnings. The iShares Russell 2000 Small-Cap Value ETF (IWN) has lost about 39% in the past year and serves as a useful ETF benchmark comparison for these companies. Healthcare – Diagnostics: Home Diagnostics (HDI ... Continue reading »

A Bullish Outlook for Generic Drugs After Election CPD

76%

-39.78% in 11 days (closed on 11/15/08) A Bullish Outlook for Generic Drugs After Election In addition to the favorable underlying trends I wrote about previously for the generic drug industry, both presidential candidates are bullish on the industry with the following excerpts taken directly from their websites: Senator Obama : Lower drug costs by allowing the importation of safe medicines from other developed countries, increasing the use of generic drugs in public programs and taking on drug companies that block cheaper generic medicines from the market. Senator McCain : R ... Continue reading »

Generic Drug Industry Outpaces Drug & Healthcare ETFs CPD

76%

+4.57% in 20 days (closed on 11/04/08) Generic Drug Industry Outpaces Drug & Healthcare ETFs The accompanying table presents statistics and the top five rated companies in the ETFI Global Generic Drug Index, which includes a total of 44 companies. Over the past year, generic drug companies have outpaced both the Healthcare Sector SPDR (XLV) and existing drug ETFs such as PowerShares Dynamic Pharma (PJP), Pharma HOLDRs (PPH), iShares Dow Jones US Pharma (IHE), and the S&P Pharma SPDR (XPH). All of the top five rated generic drug companies and over two-thirds of the 44 companies in the index are b ... Continue reading »

From the Blogosphere

Investing in India's Generic Drug Market

The accompanying table includes the Top 25 rated companies with market caps over $50M U.S. Dollar which are included in the ETF Innovators ((ETFI)) Indian Generic Drug Index as a major component in the Global Generic Drug Index. The index also includes three companies based outside of India – Akorn (AKRX), Caraco Pharma (CPD), and Taro Pharma (TAROF.PK). Akorn has a joint venture with Strides Arcolab (Akorn-Strides, LLC) which is focused on the hospital market for generic injectables, dominated by Hospira (HSP) and APP Pharma, which was acquired by Fresenius Medical (FMS). Continue reading »

Analysis of Generic Drug Companies from India

76%

The accompanying table includes the Top 25 rated companies with market caps over $50M U.S. Dollar which are included in the ETF Innovators [ETFI] Indian Generic Drug Index as a major component in the Global Generic Drug Index. The index also includes three companies based outside of India – Akorn (AKRX), Caraco Pharma (CPD), and Taro Pharma (TAROF). Akorn has a joint venture with Strides Arcolab (Akorn-Strides, LLC) which is focused on the hospital market for generic injectables, dominated by Hospira (HSP) and APP Pharma, which was acquired by Fresenius Medical (FMS). Taro is involved in liti... Continue reading »

UpDown Virtual Investing: Earn Real Money with Zero Risk

76%

The ultimate risk/reward trade for virtual investing – its is free and easy to register at the UpDown and users can earn real money at the site in two ways. The first is by beating the market (S&P 500 Index) on a monthly basis and the second is by referring investors. However, the referral system is designed to encourage legitamte referals only by basing the payment on how much the referred person earns on the site. So, if you refer someone who earns $100, you will receive 10% or $10 as a referral bonus. All money earned at the site is paid via PayPal so you will need a valid account and em ... Continue reading »

MFI Stock List Additions for Week Ending November 21, 2008

N/A

Here are the latest additions to the MFI stock universe: Advanced Battery Technologies Inc. (ABAT) Caraco Pharmaceuticals Laboratories Ltd. (CPD) Cliffs Natural Resources Inc. (CLF) Digital River Inc. (DRIV) FMC Technologies Inc. (FTI) GigaMedia Ltd. (GIGM) Interval Leisure Group Inc. (IILG) MTS Systems Corp. (MTSC) MasterCard Inc. (MA) NCR Corp. (NCR) NII Holdings Inc. (NIHD) Open TV Corp. (OPTV) Techwell Inc. (TWLL) Tyco International Ltd. (TYC) Wet Seal Inc. (WTSLA) Zimmer Holdings Inc. (ZMH) To qualify for the list, a stock must appear for the first time in the past six months in the top 100 for any of ... Continue reading »

10 Under the Radar Small & Micro-Cap Value Stocks (Healthcare)

76%

The accompanying table presents 10 small and micro-cap companies from a variety of industries which are trading at value parameters, with average valuations for the group of 0.54X trailing 12-month sales, 0.44X enterprise value to sales, 0.88X book value, and 8.7X trailing 12-month earnings. The iShares Russell 2000 Small-Cap Value ETF (IWN) has lost about 39% in the past year and serves as a useful ETF benchmark comparison for these companies. Healthcare – Diagnostics: Home Diagnostics (HDIX) is a maker of blood glucose monitoring systems and supplies under the TRUE and Prestige brands, in ... Continue reading »

Trade CPD Now
and Get 30 Free Trades »

... more »  

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.